Reference Intervals of Routine Coagulation Assays During the Pregnancy and Puerperium Period

被引:34
|
作者
Gong, Jiao-Mei [1 ]
Shen, Yong [2 ]
He, Yan-Xia [1 ]
机构
[1] Zhengzhou Univ, Dept Clin Lab, Affiliated Hosp 2, 2 Jingba Rd, Zhengzhou 450014, Jinshui Dist, Peoples R China
[2] Zhengzhou Univ, Affiliated Tumor Hosp, Henan Tumor Hosp, Dept Clin Lab, Zhengzhou, Peoples R China
关键词
coagulation assays; pregnancy; puerperium; reference intervals; STA-R; D-DIMER; WOMEN; HEMOSTASIS; FIBRINOGEN; ANALYZER;
D O I
10.1002/jcla.21956
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
BackgroundSignificant changes occur in the coagulation and fibrinolytic systems during pregnancy and puerperium in the plasma levels. However, reference ranges based on healthy people are not optimal for informing clinical decisions during the pregnancy and puerperium. Therefore, it is essential to explore coagulation assays' reference ranges during the pregnancy and puerperium. MethodsProthrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), fibrinogen (Fib.), and D-dimer were all measured according to the manufacturer's specifications and laboratory standard operating procedure of the STA-R evolution coagulation analyzer. A total of 11,601 women were enrolled in this study. ResultsThe reference ranges for PT, APTT, TT, Fib., and D-dimer in nonpregnancy period were 10.87-13.76 s, 29.22-44.61 s, 15.39-20.15 s, 1.59-3.97 g/l, and 0-0.56 mg/l, respectively. In early-pregnancy period, the ranges were 11.14-14.07 s, 29.97-44.69 s, 14.92-19.03 s, 1.98-4.13 g/l, and 0-1.67 mg/l, respectively. In midpregnancy period, the ranges were 9.98-12.84 s, 28.53-40.70 s, 13.51-19.82 s, 2.63-5.19 g/l, and 0-2.81 mg/l, respectively. In late-pregnancy period, the ranges were 9.48-12.58 s, 28.61-40.80 s, 14.10-19.61 s, 2.80-5.56 g/l, and 0-27.08 mg/l, respectively. In puerperium period, the ranges were 10.85-13.72 s, 30.51-43.02 s, 15.31-19.64 s, 1.14-5.07 g/l, and 1.27-4.85 mg/l, respectively. ConclusionWe presented reference intervals for coagulation assays from the nonpregnancy to puerperium period that can be adopted in other laboratories after further validation.
引用
收藏
页码:912 / 917
页数:6
相关论文
共 50 条
  • [41] Adverse cardiovascular, obstetric and perinatal events during pregnancy and puerperium in patients with heart disease
    Guzman-Delgado, N. E.
    Velazquez-Sotelo, C. E.
    Fernandez-Gomez, M. J.
    Gonzalez-Barrera, L. G.
    Muniz-Garcia, A.
    Sanchez-Sotelo, V. M.
    Carranza-Rosales, P.
    Hernandez-Juarez, A.
    Moran-Martinez, J.
    Martinez-Gaytan, V.
    REVISTA CLINICA ESPANOLA, 2024, 224 (06): : 337 - 345
  • [42] Incidence of venous thromboembolism during pregnancy and the puerperium: a systematic review and meta-analysis
    Meng, Kaikai
    Hu, Xiaolan
    Peng, Xiaoxia
    Zhang, Zhenyu
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2015, 28 (03) : 245 - 253
  • [43] Acute recanalization therapy for ischemic stroke during pregnancy and puerperium
    Richardt, Anna
    Aarnio, Karoliina
    Korhonen, Aino
    Rantanen, Kirsi
    Verho, Liisa
    Curtze, Sami
    Laivuori, Hannele
    Gissler, Mika
    Tikkanen, Minna
    Ijaes, Petra
    JOURNAL OF NEUROLOGY, 2024, 271 (07) : 4046 - 4056
  • [44] Etiology of intracerebral hemorrhage during pregnancy or puerperium: A nationwide study
    Vest, Teresa
    Rantanen, Kirsi
    Verho, Liisa
    Aarnio, Karoliina
    Korhonen, Aino
    Richardt, Anna
    Strbian, Daniel
    Gissler, Mika
    Laivuori, Hannele
    Tikkanen, Minna
    Ijas, Petra
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (03)
  • [45] A safety evaluation of aripiprazole for treating schizophrenia during pregnancy and puerperium
    Gentile, Salvatore
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (12) : 1733 - 1742
  • [46] Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium
    Mazzucchelli, I
    Onat, FY
    Ozkara, C
    Atakli, D
    Specchio, LM
    Neve, AL
    Gatti, G
    Perucca, E
    EPILEPSIA, 2006, 47 (03) : 504 - 509
  • [47] The Safety of Medications for the Treatment of Bipolar Disorder During Pregnancy and the Puerperium
    Dodd, Seetal
    Berk, Michael
    CURRENT DRUG SAFETY, 2006, 1 (01) : 25 - 33
  • [48] Folate supplementation during the preconception period, pregnancy and puerperium Polish Society of Gynecologists and Obstetricians Guidelines
    Bomba-Opon, Dorota
    Hirnle, Lidia
    Kalinka, Jaroslaw
    Seremak-Mrozikiewicz, Agnieszka
    GINEKOLOGIA POLSKA, 2017, 88 (11) : 633 - 636
  • [49] Venous thromboembolism during pregnancy and postpartum period
    Bukhari, Syed
    Fatima, Shumail
    Barakat, Amr F.
    Fogerty, Annemarie E.
    Weinberg, Ido
    Elgendy, Islam Y.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 97 : 8 - 17
  • [50] Headache and migraine during pregnancy and puerperium: the MIGRA-study
    Elisabeth Volden Kvisvik
    Lars Jacob Stovner
    Grethe Helde
    Gunnar Bovim
    Mattias Linde
    The Journal of Headache and Pain, 2011, 12 : 443 - 451